April 29, 2008 – Nucletron will showcase its Oncentra Brachy, a comprehensive volume-based treatment planning system to optimize cancer treatment planning with brachytherapy, at the 2008 World Congress of Brachytherapy in Boston, MA from May 4-6.

Oncentra Brachy, reportedly the world’s first fully DICOM-compatible treatment planning system, features optimization algorithms designed to ensure efficient treatment. The new solution provides 3D contouring and margining tools to identify Regions of Interests (ROIs) on CT or in a multimodality imaging environments using image registration for CT, MR and PET data.

Oncentra Brachy is made to provide faster and easier creation of treatment plans, ranging from simple to complex, in user-defined workspaces that allow for adaptation to specific clinical workflows. Real-time information sharing provides immediate access for the entire medical team and aims to facilitate the exchange of treatment plans over vast distances with decentralized planning capabilities. Physicians are able to evaluate and authorize treatment plans remotely.

The system has not received regulatory clearance in North America.

For more information: www.nucletron.com


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Lung Imaging

Oct. 20, 2026 — Optellum has announced that its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI is ...

Time October 21, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Prostate Cancer

Aug. 13, 2026 — Artera has announced the enrollment of the first patient in its DIRECT-AI registry study, marking the ...

Time August 14, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Subscribe Now